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Abstract Rat adrenals contain a lipase activity that is indistin- 
guishable from hepatic lipase (HL) present in liver. Expression 
of H L  mRNA in adrenals was studied using the method of 
reverse transcription-polymerase chain reaction (RT-PCR). A 
596-bp fragment of H L  cDNA spanning exons 5 to 8 was am- 
plified when using total RNA from rat adrenals and liver, but 
not from heart or kidney. The abundance of H L  mRNA was 
quantified by competitive RT-PCR using a standard RNA that 
was generated in vitro by transcription from a deleted HL 
cDNA construct. Adrenals contained 0.4 attomoles of HL 
mRNA per pg of total RNA, compared to 16 attomoles in 
liver. In hypertrophic adrenals isolated from corticotrophin- 
treated rats, the abundance also amounted to 0.4 attomoles of 
mRNA per pg of total RNA. However, amplification of full- 
length cDNA from either control or hypertrophic adrenals was 
never observed. Detailed analysis by PCR using different combi- 
nations of primers indicated that exons 3 to 9 including the 
3'-untranslated region were expressed in adrenal RNA, but not 
the first two coding exons. The upstream part of the adrenal l i -  
pase mRNA was cloned after rapid amplification of cDNA ends 
(RACE). The resulting clones showed a unique 126-bp sequence 
5' of the exon 2-exon 3 junction. This sequence contained multi- 
ple termination codons in all three reading frames but lacked a 
potential start codon. RT-PCR using an HL-specific primer and 
an oligonucleotide directed against this 5'-sequence showed that 
it  is not only expressed in RNA from adrenals but also in liver. 
Pulse-labeling of freshly isolated adrenocortical cells with 
[35S]methionine followed by immunoprecipitation with anti-HL 
antibodies failed to show synthesis of mature HL, but indicated 
the synthesis of immunoreactive proteins in the 40-45 kDa 
range that remained mainly intracellular. I Hence, the HL 
gene is transcribed in adrenals but results in an rnRNA species 
with a unique 5'-end. Translation from an internal start site may 
produce an intracellular H L  isoform that differs markedly from 
the liver-type lipase previously identified in adrenals. - 
Verhoeven, A. J. M., D. Carling, and H. Jansen. Hepatic li- 
pase gene is transcribed in rat adrenals into a truncated mRNA. 
J Lipid Res. 1994. 35: 966-975. 
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Hepatic lipase (HL; E.C. 3.1.1.34) is present in the liver 
of most vertebrates at the endothelial lining of blood sinu- 
soids (1). The enzyme plays a central role in lipoprotein 
metabolism. Notably, H L  is shown to facilitate uptake by 
liver cells of cholesterol from high density lipoproteins 
(HDL) (1-3). A highly similar enzyme activity (liver-type 
lipase) has been detected in rat, human, hamster, and bo- 
vine adrenal cortex (4-6) and in rat ovaries (6-8). At least 
in the rat, these organs depend largely on H D L  
cholesterol as the source for steroidogenesis (9, 10). The 
liver-type lipase activity is almost exclusively localized in 
the zona fasciculata and the corpora lutea (8, 11, 12), 
which are most active in steroid hormone production. In  
addition, the enzyme activity in these organs varies in 
parallel with steroid output (7 ,  13, 14), suggestive of a n  
important role in cholesterol supply. 
The  liver-type lipases from rat adrenals and ovarie: 
closely resemble H L  from the liver. These enzymes sharc 
the properties of salt-resistance and alkaline pH-  
optimum, all three are released from the respective organ: 
by heparin infusion, and show similar affinities foi 
Sepharose-heparin (6, 15). Moreover, all three enzyme: 
are equally recognized by polyclonal and monoclonal an. 
tibodies prepared against rat H L  (6, 16). Finally, the pep 
tide map of adrenal lipase made by digestion witf 
V8-protease is similar to that of H L  (17). These observa 
tions strongly suggest that all three lipases represent a sin 
gle gene product. 
H L  is synthesized and subsequently secreted b) 
hepatocytes. The origin of the liver-type lipases ir 
adrenals and ovaries remains unknown. Attempts to de- 
tect local de novo synthesis in unstimulated rat adrenals 
and highly luteinized ovaries by [35S]methionine incorpo- 
ration into immunoreactive protein have been unsuccess- 
ful (17, 18). H L  mRNA has never been observed in 
Abbreviations: ACTH, adrenocorticotrophic hormone; bp, base pairs; 
BSA, bovine serum albumin; GAPDH, glyceraldehyde 3-phosphate de- 
hydrogenase; HDL, high density lipoproteins; HL,  hepatic lipase; nt, 
nucleotide; PCR, polymerase chain reaction; RACE, rapid amplifica- 
tion of cDNA ends; RT, reverse transcription; TBE, Tris-borate-EDTA 
buffer; TE, Tris-EDTA buffer. 
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adrenals and ovaries by classical Northern blotting 
(17-20), or in ovaries by application of the polymerase 
chain reaction (18). This led to the hypothesis that the 
liver-type lipases are synthesized exclusively in the liver 
and subsequently transported to the adrenals and ovaries. 
However, in initial experiments we found that part of the 
HL mRNA could be detected by RT-PCR in RNA from 
adrenals, ovaries, and testes, but not in heart or kidney 
(21). In the present study, we elaborated on this finding 
and studied the abundance, nature, and possible translation 
product of the HL gene transcript in the rat adrenal gland. 
MATERIALS AND METHODS 
RNA isolation 
Male Wistar rats (250-300 g) were killed by decapita- 
tion, and the blood was allowed to drain. Then, organs 
were quickly excised. Adrenals were collected directly in 
liquid nitrogen; liver, heart, and kidney were cut into 
pieces and also dropped in nitrogen. The tissues were 
stored at -7OOC until use. Hypertrophic adrenals were 
obtained from animals after 5-9 daily injections with 50 
pg of a synthetic corticotrophin analogue (Synacthen, 
Ciba-Geigy N.V., Belgium), as detailed previously (13). 
Total RNA was isolated from individual adrenals, or from 
0.25-0.50 g of tissue by the acid-guanidinium 
thiocyanate-phenol method (22). RNA concentrations 
were determined by spectrophotometry at 260 nm (23). 
The quality of the RNA preparations was judged from the 
ratio of 28s over 18s ribosomal RNA after denaturation 
and electrophoresis in a 1% agarose/TBE gel (23). Alter- 
natively, 1 pg of denatured RNA was analyzed by North- 
ern blotting using a 3*P-labeled 18s ribosomal RNA anti- 
sense oligonucleotide (5'-ACG GTA E T  GAT CGT 
CTT CG-3', nt 1070-1051, ref. 24) as probe. 
Oligonucleotide primers 
Oligonucleotides (cf. Fig. 3A) were synthesized with 
the PCR-Mate 391 DNA synthesizer (Applied Bi- 
osystems). HL-1 (5'-GTG GGC A X  AAA CAG CCC-3', 
nt 712-729) and HL-2 (5'-CAG ACA TTG GCC CAC 
ACT G-3', nt 1307-1289; numbering according to the rat 
cDNA sequence, ref. 19) were used for quantitative RT- 
PCR. According to the genomic DNA sequence of human 
HL, this fragment extends from exon 5 into exon 8 with 
more than 14 kb intron sequence (25, 26). Full-length HL 
cDNA was amplified using HL-4 (5'-GGT AAG ACG 
AGA GAC ATG GG-3', nt 1-20) and HL-5 (5'-CCT 
TTG TGT AAT TTG GCT TCC G-3', nt 1602-1581). 
Other HL-specific primers mentioned in the text were 
HL-3 (5'-CGG GGG C E  CTT CCA GCC TGG-3', nt 
C-3', nt 403-421), HL-12 (5'-TGG CTT GCT AGA AAC 
741-761), HL-7 (5'CAC TAT GCT ATT GCC GTG 
CTG G-3', nt 297-315), HL-13 (5'-TGT CAT GAT CAT 
CCA CGG G-3', nt 267-285) and AHL-13 (5'-CCC GTG 
GAT GAT CAT GAC-3', nt 285-268). For PCR of 
GAPDH cDNA (27), the oligonucleotides GAPDH-1 
( 5 ' - C X  E T  TGC X T  CAG TAT CC-3', nt 1120-1101) 
and GAPDH-2 ( 5 ' - E T  E T  TGT GCA GTG CCA 
GC-3', nt 35-54), which span the entire coding sequence, 
were used. Combinations of primers employed in RT- 
PCR always framed at least one intron of genomic DNA. 
RT-PCR 
First-strand cDNA synthesis and subsequent amplifica- 
tion by PCR was performed in a single tube starting with 
1 pg of total RNA. Immediately before use, the RNA was 
heated for 3 min at 7OOC. First-strand synthesis was per- 
formed in a total volume of 20 p1 containing 50 mM KCl, 
10 mM Tris/HCl (pH 8.3), 5 mM MgC12, 1 mM of each 
dNTP, 50 pmol random hexamers, 20 U RNAsin, and 50 
U of M-MLV reverse transcriptase (Perkin-Elmer Cetus). 
Incubations were performed in a DNA Thermal Cycler 
(Perkin-Elmer Cetus) for 10 min at room temperature, 
followed by 30 min at 42OC and 5 min at 99OC. There- 
after, the total incubation volume was adjusted to 100 p1 
by adding pre-mixed components, and overlaid with 50 p1 
of light mineral oil (Sigma, St. Louis, MO); final concen- 
trations were 50 mM KCl, 10 mM Tris/HCl (pH 8.3), 2 
mM MgC12, 0.2 mM of each dNTP, 15 pmol each of an 
upstream and downstream primer, and 2.5 U Taq DNA 
polymerase (Perkin-Elmer Cetus). After incubation for 2 
min at 94"C, amplification was performed in 35 cycles of, 
successively, 1 min 94OC, 1 min 55OC, and 1 min 72OC, 
unless otherwise stated. Possible carry-over of PCR 
products or contamination with cDNA-containing plas- 
mids was assessed by performing parallel incubations in 
the absence of reverse transcriptase. A no-template con- 
trol was included in each experiment. The PCR products 
were analyzed by separating 10-p1 aliquots on a 3% 
agarose/TBE gel (Nusieve:Seakem = 3:l; FMC Bio- 
products, Vallensbaek Strand, Denmark). 
Semi-quantitative RT-PCR 
Quantitation of HL mRNA was done by competitive 
RT-PCR (28). In this assay, 0.5 pg of tissue RNA was 
mixed with 0.5 pg of yeast RNA containing increasing 
amounts of competitor RNA, and then reverse tran- 
scribed and amplified as described. Semi-quantitation 
was done visually by comparing the intensities of the 
ethidium bromide-stained bands on agarose gels. The 
competitor RNA was generated in vitro from an HL 
cDNA construct in which an 80-bp Sau3A fragment (nt 
1009-1088) was deleted. Liver cDNA was amplified using 
the primers HL-1 and HL-2, and the resulting 596 bp 
DNA product was partially digested with Sau3A. The 296 
bp and 219 bp restriction fragments were gel-purified, re- 
ligated and re-amplified with HL-1 and HL-2. The 516 bp 
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product was TA-cloned (29) into pBluescript (Stratagene, 
La Jolla, CA). A recombinant plasmid was selected that 
contained the insert in the sense orientation with respect 
to the T7 promoter. The plasmid was linearized by diges- 
tion with PvuII, which cuts the vector at about 300 bp 
downstream of the insert, thereby providing a 3'-tail for 
random priming comparable in size to that in the target 
mRNA. After linearization, the DNA template (approx. 
0.5 pg) was transcribed for 2 h at 40°C with T7 RNA 
polymerase (400 U/ml; Promega) in the presence of 40 
mM Tris-HC1 (pH 7.5), 6 mM MgC12, 2 mM spermidine, 
10 mM dithiothreitol, 5 mM NaCl, 100 pg/ml of BSA, 0.5 
mM of each ribonucleotide, and 4000 U/ml of RNAsin. 
Thereafter, the DNA was digested with 400 U/ml of 
RNAse-free DNAse I (Boehringer Mannheim, Germany) 
for 30 min at 37°C. The RNA was extracted with phenol- 
chloroform and ethanol-precipitated. After resuspension 
in TE, the RNA concentration was measured by spec- 
trophotometry at 260 nm, and then the RNA was serially 
diluted into T E  containing 0.5 pg/ml of yeast RNA. 
Rapid amplification of 5'-cDNA (5'-RACE) 
5'-RACE was performed in principle according to 
Frohman, Dush, and Martin (30). First-strand cDNA was 
synthesized from 4 p g  adrenal total RNA using 
oligo(dT),6 as primer. After ultrafiltration through 
Centricon-100 (Amicon), the cDNA was G-tailed by incu- 
bation with 5 p M  dGTP and 25 units of terminal 
deoxynucleotidyl-transferase (Pharmacia, Uppsala, 
Sweden) for 30 min at 37OC in a final volume of 20 pl. Af- 
ter inactivation of the enzyme for 5 min at 65OC, the 
volume was brought to 150 pl with TE. Then, 10 p1 of this 
solution was subjected to nested PCR (30 cycles; 1 min 
94OC, 1 min 58OC, 1 min 72OC; 100 p1 final volume) us- 
ing primers against the G-tail and various HL-specific 
oligonucleotides. In the first round of PCR, a mixture of 
20 pmol of a hybrid dC17-adapter primer (5'-AAG GAT 
CCG TCG ACA TCG ATA ATA CGA CTC ACT ATA 
AGG GAC CCC CCC CCC CCC CCC (2-3') and 80 
pmoles of the adapter primer (5'-GAT AAT ACG ACT 
CAC TAT AAG GGA-3') were used, whereas subsequent 
rounds of PCR were performed with 60 pmol of the adap- 
ter primer. Two strategies of nested PCR were followed 
using 60 pmol of different HL-specific primers. z) After 
the first round using HL-2, the mixture was diluted 
10-fold into a fresh incubation and PCR was performed 
with HL-14; ii) HL-5 was used in the first round, HL-7 
in the second, and HL-14 in the third round. After gel- 
purification of the PCR products and TA-cloning into 
pBluescript, double-strand sequencing was performed by 
the dideoxy termination method (31) using vector-specific 
oligonucleotides as primers. 
Pulse-labeling with [35S]methionine 
Adrenocortical cells were freshly isolated from the 
adrenals of five rats that had been treated with ACTH for 
5-6 days, as described above. After removing the sur- 
rounding fat, the adrenals were minced and then shaken 
for 50 min at 37OC with collagenase (Sigma, type I; 3 
mg/ml). Intact adrenocortical cells were isolated by cen- 
trifugation (10 g room temperature, 5 min) through a 
layer of 2% BSA in Krebs-Ringer solution. The cells were 
divided into six vials, and incubated for the times indi- 
cated at 37OC with 100 pCi Tran35S label (ICN, Irvine, 
CA) in methionine-free Ham's F10 medium containing 
20% lipoprotein-free human serum (after dialysis), 10 
U/ml heparin and 0.6 mU/ml ACTH. The incubations 
were stopped on ice, and cold methionine (1 mM, final 
concentration) was added. The cells were separated from 
the extracellular medium by centrifugation (1 min, 10,000 
g, 4OC), and then resuspended and lysed in 0.5 ml PBS 
containing 1% Triton X-100, 0.1% SDS, 1 mM methio- 
nine, and protease inhibitors (100 U/ml Trasylol, 5 pg/ml 
leupeptin, 1 mM PMSF, 100 pg/ml benzamidine, and 1 
mM EDTA); after 30 min on ice, the lysates were cen- 
trifuged (5 min, 10,000 g, 4OC) and the supernates were 
used for immunoabsorption. Protease inhibitors were ad- 
ded to the extracellular media in the same final concentra- 
tions. In parallel, rat hepatocytes were freshly isolated by 
collagenase perfusion (32), and pulse-labeled with 
label as described above. 
35S-1abeled H L  and HL-related proteins were collected 
from cell lysates and extracellular media by immunoab- 
sorption to Sepharose-coupled goat polyclonal anti-HL 
IgGs. The samples were first treated for 3 h at 4OC with 
50 pl of a 50% slurry of Sepharose coated with goat IgGs 
prepared from nonimmune serum. After centrifugation 
(30 sec, 10,000 g, 4OC), the supernates were incubated 
overnight at 4OC with 50 p1 of a 50% slurry of anti-HL 
coated Sepharose. Thereafter, the beads were collected by 
centrifugation, and washed twice with 1 ml of, succes- 
sively, 1% Triton X-100 in PBS, PBS, 2 M NaCl in PBS, 
and finally PBS. The absorbed proteins were released by 
10-min boiling in 15 p1 of Laemmli's sample buffer, and 
separated by electrophoresis through an SDS-containing 
10% -polyacrylamide gel. Radioactive bands were visual- 
ized according to standard procedures by fluorography 
using Amplify (Amersham). The immunoglobulins used, 
as well as their coupling to Sepharose, have been 
described elsewhere (32). 
Alternatively, HL-related proteins were collected by 
immunoprecipitation with a mixture of five different 
monoclonal anti-HL IgGs (16). After pre-clearing with 
protein A-Sepharose 4B (Pharmacia, Uppsala, Sweden), 
the cell lysates and extracellular media were incubated for 
1 h at 4°C with 25 pl each of five different hybridoma su- 
pernatants, followed by a 1-h incubation with 10 pl of 
whole rabbit anti-mouse IgG antibodies (1 mg/ml; Nordic 
Immunology, Tilburg, The Netherlands). Thereafter, 50 
pl of a 50% slurry of protein A-Sepharose 4B was added, 
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V and the incubation was continued for 16 h at 4OC. The 
beads were collected. and treated further as described above. 
RESULTS 
Detection of HL mRNA in rat adrenals 
RT-PCR of total liver RNA using the HL-specific 
oligonucleotides HL-1 and HL-2 yielded one major 
product with the expected size of 596-bp (Fig. 1A). A 
similarly sized product was obtained with RNA isolated 
from whole adrenals. No such product was generated in 
the absence of reverse transcriptase. Identity of this PCR 
product with part of the H L  cDNA was confirmed by res- 
triction mapping and internal re-amplification (21). Iden- 
tical results were observed when oligo(dT)t6 was used to 
prime cDNA synthesis (21), which might indicate that the 
RNA target contained a poly-A tail. Amplification was 
observed with each of twelve independent RNA prepara- 
tions from different adrenals. Under the same conditions 
RT-PCR on heart and kidney RNA remained negative. In 
contrast, the full-length cDNA of GAPDH was amplified 
with RNA from these tissues as well as liver and adrenals 
(Fig. 1B). Control experiments showed that the RNA 
preparations used all contained comparable amounts of 
18s and 28s ribosomal RNA, indicating that the quality 
of these preparations was highly similar. These results 
demonstrate that at least part of the H L  gene is tran- 
scribed in rat adrenals, but not in heart and kidney. 
Quantitation of HL mRNA 
To assess the abundance of H L  mRNA in adrenals 
relative to liver, RT-PCR was performed as described 
above except that product formation was monitored after 
successive rounds of amplification. With 1 pg of adrenal 
L A H K w  
I GAPDH - 1086 
Fig. 1. Detection of HL mRNA by RT-PCR in rat adrenals. RT-PCR 
was performed with RNA from liver (L), adrenal (A), heart (H). and 
kidney (K), and a no-template control (w). After first-strand cDNA syn- 
thesis, the incubation mixture was split into two aliquots for amplifica- 
tion of the H L  cDNA (upper panel) and almost full-length cDNA encod- 
ing for GAPDH (nt 35-1120; lower panel). Amplification was for 35 (HL 
mRNA) or 25 cycles (GAPDH mRNA). 
0.1 1 2 4 10 100 
A 
V 
- 698 
- 616 
contrd 
V 
+ACTH -1 696 I 616 I 
0.01 0.1 0.2 0.s 1 10 
B 
Fig  2. Quantitation of HL mRNA in liver and adrenals. Competitive 
R1-PCR was performed on liver RNA (A), and on adrenal RNA (€3) iso- 
lated from either untreated (upper panel) or ACTH-treated rats (lower 
panel). To 0.5 pg of tissue RNA, the indicated amounts (in attomoles) 
of the deleted HL RNA competitor were added. Amplification was for 
25 cycles (liver) or 35 cycles (adrenals). The arrowheads indicate the 
lanes where the 596 and 516-bp bands show equal intensities under UV. 
RNA, the 596-bp DNA band became UV-detectable after 
28-30 cycles, whereas with 1 pg of liver RNA this band 
was already observed after 20 cycles. Then, liver RNA 
was serially diluted into yeast RNA and subjected to RT- 
PCR in parallel with undiluted adrenal RNA. With 
10-20 ng of liver RNA, the RT-PCR product became ap- 
parent after a similar number of cycles as with 1 pg of 
adrenal RNA (not shown). This indicated that the abun- 
dance of H L  mRNA in whole adrenals is about 1-276 of 
that in liver. 
Next, the amount of H L  mRNA in liver and adrenals 
was quantitated by competitive RT-PCR. An internal 
standard RNA was generated that contained the H L  se- 
quence framed by the primers HL-1 and HL-2 except for 
an internal 80-bp fragment. Known amounts of competi- 
tor H L  RNA lacking an internal 80-bp fragment were 
mixed with 0.5 pg of tissue RNA and then subjected to 
RT-PCR. When the competitor RNA was increased from 
0.01 to 100 attomoles, the amount of the 516-bp PCR 
product increased whereas the 596-bp PCR product from 
the endogenous H L  mRNA gradually disappeared (Fig. 
2). By interpolation, both PCR products showed equal 
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signal intensities when liver and adrenal RNA were 
mixed with 8 and 0.2 attomoles of standard RNA, respec- 
tively. These results indicate that liver contains approxi- 
mately 16 attomoles of H L  mRNA per pg total RNA. The 
abundance in adrenals is 40-fold less at 0.4 attomoles per 
pg of total RNA. Identical results were obtained for at 
least one other liver and adrenal. 
Expression of HL mRNA in hypertrophic adrenals 
Treatment of rats with ACTH resulted in a marked in- 
crease in adrenal volume. Accordingly, the amount of to- 
tal RNA isolated from these organs increased 3-fold from 
43 * 10 pg (n = 3) to 132 k 31 (n = 6) pg per adrenal 
(means k SD). By competitive RT-PCR on adrenals from 
two different rats, 0.4 attomoles of mRNA was found per 
1 pg of total RNA, similar to the number found for un- 
treated adrenals (Fig. 2B). This indicates that, within the 
limits of detection, the H L  gene transcript is not 
specifically induced by ACTH treatment. Rather, the total 
number of H L  mRNA molecules per adrenal increases in 
parallel with the increase in tissue volume and total RNA. 
Is the entire HL mRNA expressed in adrenals? 
Full-length cDNA (nt 1-1602) was readily amplified 
from a liver RNA preparation using the oligonucleotides 
HL-4 and HL-5 as primers. In contrast, several attempts 
to detect the entire mRNA in adrenals from either un- 
treated or ACTH-treated rats by RT-PCR remained 
negative. Using HL-1 and HL-5, the expected RT-PCR 
product of 891-bp was obtained with adrenal as well as 
liver RNA, demonstrating the presence of the 3'-end of 
the mRNA including the 3'-untranslated region (Fig. 3). 
I 4 8 4 5 
RT-PCR was then performed using HL-5 as the down- 
stream primer, and a number of different sense primers. 
Amplification was obtained with HL-7 and HL-12. Upon 
Southern blotting, these PCR products hybridized to an 
internal oligonucleotide, HL-3, demonstrating the 
specificity of the reaction. With HL-13, which anneals to 
H L  cDNA only 30 bp upstream of HL-12, however, the 
expected RT-PCR product of 1336-bp was obtained with 
liver RNA, but not with adrenal RNA. Using HL-4 or 
any of three other primers upstream of HL-13, RT-PCR 
on adrenal RNA remained negative (data not shown). In 
addition, amplification of the sequence between HL-13 
and one of two other anti-sense primers upstream of 
HL-2 was never observed. Moreover, the combination of 
HL-4 and AHL-13, an oligonucleotide antisense to 
HL-13, failed to give a PCR product. Identical results 
were obtained with RNA isolated from control and hyper- 
trophic adrenals. In all cases, a DNA product of expected 
size was generated by parallel RT-PCR on liver RNA, 
which served as a positive contlpl. These observations 
strongly suggest that the H L  mRNA found in liver is also 
expressed in normal and hypertrophic adrenals except for 
the 5'-end upstream of HL-12. 
Identification of the d'-end of adrenal lipase mRNA 
5'-RACE was performed on adrenal RNA using two 
different strategies of nested PCR with HL-specific 
primers. Both strategies yielded a visible DNA product of 
approximately 250-bp, that hybridized with HL-12 but 
not with HL-13. Both products were cloned and se- 
quenced. The two independent PCR products were 
almost identical, except that clone 1 extended 18 bp fur- 
6 7 8 9 
I I I I I I I I 
c- f- 
2 6 
A 
HL-1 HL-7 HL-12 HL-13 
Fig. 3. Adrenal HL mRNA does not contain the 5'-end of the liver 
counterpart. A: Depicts the exon organization of rat HL cDNA, which 
is inferred from the one established for human HL cDNA (24, 25). The 
open bar indicates the coding sequence with the exon numbers given 
above. The closed bars represent the untranslated regions. The arrows 
define the positions of all the oligonucleotides used in RT-PCR on 
adrenal RNA with the arrowheads pointing in the 3'-direction; the 
n i  i names of onlv those orimen that are mentioned in the text are given. R: 
- 1356 - 1506 
1200 - --. 
RT-PCR wa, perfoimed on liver (L) and adrenal (A) RNA, and a 
parallel water control (w) using HL-5 as the downstream primer. After 
first-strand cDNA synthesis, the incubation was split into four aliquots 
for amplification with different upstream primers, as indicated on top of 
the lanes. 
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ther upstream than clone 2, and had a slightly shorter 
oligo(dC) stretch at its 5'-end reflecting a shorter G-tail of 
first-strand cDNA (Fig. 4). In addition, four single base 
differences were apparent along the sequence, probably 
due to the infidelity of the Taq DNA polymerase reaction; 
no attempts were made to resolve these ambiguities. The 
3'-ends of both sequences were identical to part of the H L  
cDNA corresponding to exon 3 (nt 292-313, numbering 
according to ref. 19). The homology with H L  cDNA, 
however, was completely lost upstream of base 292, where 
exon 3 is supposedly joined to exon 2 according to the or- 
ganization of the human H L  gene (25, 26). Instead, 
126 bp of n o d  sequence were found upstream of this junction. 
Closer inspection of this novel sequence revealed the 
complete absence of an ATG triplet. Moreover, multiple 
termination codons are present in all three reading 
frames. The dinucleotide AG at positions - 2  and -1 
combined with the pyrimidine-rich stretch between -17 
and -3 conforms to the consensus sequence for intron- 
exon boundaries (33). Taken together, this novel sequence 
has intron-like features, and might represent the intron 
upstream of exon 3 in the H L  gene. Unfortunately, to the 
best of our knowledge, the sequence of the rat H L  gene 
at this splice junction has not yet been determined. 
A sense oligonucleotide (INT) was made according to 
the sequence of clone 1 (position -112 to -93), and used 
in RT-PCR on adrenal and liver RNA in combination 
with HL-9, which recognizes the H L  gene in exon 5 (25, 
26, 34, 35). A band of the expected 481-bp was produced 
with adrenal RNA from control as well as from ACTH- 
treated rats (Fig. 5B). Surprisingly, RT-PCR on liver 
RNA gave a similar product. Formation of these PCR 
products was only seen when reverse transcriptase was in- 
cluded in the initial incubation mixture; even after 
Southern blotting, no hybridizing band was observed with 
32P-labeled HL-12 in the -RT controls (not shown). 
Hence, these results are not due to contamination with 
genomic or any other DNA sequences. Similar results 
were obtained with HL-2 as the anti-sense primer, which 
is targeted at exon 8 of the H L  gene (not shown). These 
data confirm that the new sequence is expressed in the 
RNA contiguous with H L  mRNA. Moreover, the possi- 
bility that this RNA species represents immature, un- 
spliced H L  RNA seems unlikely because several introns 
are spanned by the primer combinations used, and the 
observed product sizes fit perfectly with that of mature, 
fully spliced H L  cDNA. 
Apparently, the truncated H L  mRNA species initially 
-126 
1. C,, Goo AGA AAG ATC CAT TOT CCT GCC T(3A GGA -91 
2 .  -A- C,, G- -  _ - _  _ - -  _ _ _  _ _ _  
1. 
2.  
1. 
2.  
HL . 
- 1  
291 + exon 3 
Fig. 4. 5'-RACE of the adrenal HL gene transcript. Two independent clones were obtained by 5'-RACE using 
two different strategies of nested PCR with HL-specific primers. Both strands of each insert were sequenced using 
vector-specific oligonucleotides; only part of the sequence between the adapter primer and HL-14 that were used 
in the last round of nested PCR is given here. The sequence of clone 2 is compared with that of clone 1, and with 
part of HL cDNA comprising the junction between exon 2 and 3. Bases that are identical to the clone 1 sequence 
are indicated by hyphens. The sequence corresponding to exon 3 is boxed, whereas the possible termination codons 
are underlined. The numbering above the nucleotide sequence indicates the position upstream of the exon 3 se- 
quence, whereas the number beneath the HL sequence indicates the position in the cDNA sequence (19). 
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A. 
L Ac A + w M  
481 - ml 
RT -+ -+ -+ + 
B. C. 
Fig. 5. Expression of the truncated H L  mRNA in adrenals and liver. RT-PCR was performed on RNA from liver (I,), control adrends (Ac) and 
ACTH-stimulated adrenals ( A + )  using HI.-9, and either INT. which recognizes the novel sequence idcntifid by 5’-RACE, or HI,-12, which recoc 
nizes both full-length and truncated HI, cDNA, as indicated schematically in panel A. In panel R. PCR was performed for 35 cycles with INT and 
HI,-9 with (+ )  or without (-) inclusion of reverse transcriptase in the RT-strp. A no-template control (w) was also included. In lane M the 
q5X174-Haelll molecular size markers arc run. In panel C, PCR was performed for the indicatecl number ofcycles using INT and HI.-9 (upprr part) 
or HL-12 and HL-9 (lower pan). 
found in adrenals is also present in liver (Fig. 5A). Using 
INT and HL-9, a UV-detectable RT-PCR product of the 
truncated message was observed after 30 cycles of am- 
plification with liver RNA, similar to adrenal RNA (Fig. 
5C). In contrast, using HL-12 and HL-9, the product of 
both the truncated plus full-length message was seen after 
20 cycles with liver RNA opposed to 30 cycles with 
adrenal RNA. This finding suggests that, in liver, the 
truncated message is only a minor component compared 
to the full-length one, but represents the major, if not 
only, HL gene transcript in the adrenals. 
Pulse-labeling of adrenocortical cells 
Freshly isolated adrenocortical cells were incubated in 
suspension with [35S]methionine. At the end of the pulse, 
cells and media were separated and the radiolabeled pro- 
teins were immunoprecipitated with anti-HL antibodies. 
Fig. 6 shows the results obtained with a polyclonal IgG 
preparation; highly similar results were obtained with a 
mixture of five different monoclonals (not shown). No 
radiolabeled protein, either in the extracellular media or 
in cell lysates, was detected in the 55-60 kDa range cor- 
responding to mature HL secreted by hepatocytes. In the 
cell lysates, however, two major protein bands were ob- 
served in the 40-45 kDa range. Even after 2 h labeling 
with [35S]methionine, these bands were hardly detectable 
in the extracellular medium, indicating that these pro- 
teins remained mainly intracellular. 
49.5 - 
32.5 - 
27.5 - 
m m  m c m c  
Fig. 6. Pulse-labeling of adrenocortical cells and liver cells with 
[l’S]methionine. Freshly isolated liver parenchymal cells (L) and 
adrenocortical cells (A) werc incubated for the indicated time with 
I”S]methionine. After pulse-labeling, the cell-free media (m) and cell ly- 
sates (c) were incubated with polyclonal anti-HL I&s immobilized on 
Sepharose beads. The immunoabsorbed proteins were separated by 
SIX-PAGE on a 10% gel and visualized by fluorography. The positions 
of the pre-stained molc*cular weight markers arc indicated. 
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DISCUSSION 
The presence of an HL-like activity in the adrenal 
glands from rat and other mammals has long been recog- 
nized. In the present study, we show that the HL gene is 
transcribed in rat adrenals. An HL gene transcript was 
also detected in human adrenals, and in rat ovaries and 
testes, but not in heart and kidney (21). These findings 
suggest that expression of the H L  gene is confined to 
steroidogenic organs, at the levels of both mRNA and en- 
zyme activity. However, the transcript found in adrenals 
differs considerably from the full-length mRNA in liver. 
If this truncated message is translated, the resulting pro- 
tein would be quite distinct from H L  as well as from the 
liver-type lipase found in adrenals. The predicted protein 
would lack the N-terminal part of HL, but would have the 
same C-terminal part. Its molecular mass would be 45 
kDa at the most, depending on whether the first ATG in 
the truncated message (codon 134, according to the se- 
quence in ref. 19) is used as the translational start site, 
which is much smaller than the 58 kDa of mature HL. 
Moreover, since the signal sequence is missing in the 
truncated message, the translation product would remain 
in the cytosol. In fact, candidate proteins that meet these 
criteria were found upon immunoprecipitation from 
pulse-labeled adrenocortical cells (Fig. 6). Hence, the 
liver-type lipase found in adrenals cannot possibly be the 
product of the HL gene transcript described here. This 
study, therefore, provides strong evidence in favor of the 
hypothesis that the liver-type lipase found in adrenals is 
synthesized elsewhere, notably in liver (17, 19, 20). 
Preliminary data indicate that the HL gene transcript in 
rat ovaries also lacks the first two exons (D. Vieira, A. J. M. 
Verhoeven, and H. Jansen, in preparation), which might 
indicate that this also holds for the liver-type lipase found 
in ovaries (18). How hepatic lipase is transported to 
adrenals and ovaries remains unknown at present. In 
analogy to lipoprotein lipase (36, 37), HL may be dis- 
placed from the liver by binding to lipoproteins, which 
then target the enzyme to these steroidogenic organs. 
The finding of a novel HL gene transcript in liver, 
adrenals, and possibly ovaries, but not in heart and kid- 
ney, and the detection of candidate translation products in 
the 40-45 kDa range in adrenocortical cells suggests this 
is a unique feature of steroidogenic organs. The intracel- 
lular translation product may have an important, though 
hitherto unknown, function in steroidogenesis. Possibly, 
the truncated HL mRNA translates into a protein with 
enzymatic properties different from HL. If the 40-45 kDa 
proteins found in adrenocortical cells indeed represent the 
HL gene product, translation must have started from the 
ATG at codon 134, which is upstream of the sequence cod- 
ing for the catalytic triade (19). Hence, this protein may 
possess serine protease activity but possibly towards 
different substrates. The exon 2-exon 3 junction that 
would be missing from the adrenal product codes for the 
@5-loop as identified in the model for closely related pan- 
creatic lipase (38). This loop is proposed to interact with 
the surface loop that covers the catalytic pocket (34). For 
pancreatic lipase and lipoprotein lipase, this loop serves an 
important role in determining substrate specificity (39, 40). 
The truncated mRNA found as the major H L  gene 
transcript in adrenals, and as a small fraction of total HL 
gene transcripts in the liver, starts to diverge from the full- 
length message at base 291 (cf. ref. 19). In human HL 
cDNA this position marks the junction between the exons 
2 and 3 (25, 26). Unfortunately, the genomic organization 
of the rat gene is unknown, but the nucleotide sequences 
surrounding all the exon junctions identified for the hu- 
man cDNA are highly conserved in the rat (19). It is prob- 
ably safe to assume that the change from exon 2 to exon 
3 in the rat cDNA occurs at the same position. Therefore, 
we hypothesize that the truncated and full-length mes- 
sages represent alternate splice forms from a single, initial 
gene transcript. Alternatively, both species may originate 
from different transcriptional start sites. The possibility 
that the two mRNA species are derived from different 
genes seems less likely. First, evidence for the existence of 
more than one HL gene in the rat or human genome has 
not been reported. Second, both transcripts are recog- 
nized by HL-5, which anneals to the 3'-untranslated 
region. This part of the sequence most likely differs 
among multiple genes, as, in the absence of any selective 
pressure, noncoding sequences would have diverged much 
faster than coding sequences. 
In conclusion, we have shown here that the H L  gene is 
transcribed in adrenals as well as in liver, but not in non- 
steroidogenic organs. This suggests an important role of 
this gene in cholesterol handling in these organs. In liver, 
this gene transcribes into two mRNA species, possibly as 
the result of alternative splicing or an additional tran- 
scription start site. Only one of these splice forms is found 
in the adrenals. Apparently, the splicing or the transcrip- 
tion start site that results in full-length HL mRNA is 
completely silenced in adrenals. A similarly strict tissue- 
specificity has been reported for alternative splicing of 
several other genes such as for mouse a-amylase (41). 
How this tissue-specific expression is effected remains to 
be elucidated. The finding of a candidate protein product 
of the truncated mRNA in adrenals opens the possibility 
that the HL gene codes for two different proteins, an ex- 
tracellular enzyme produced in liver and transported to 
the steroidogenic organs and an intracellular enzyme. 
Both products may be important to steroidogenesis in 
these organs. 
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